Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches

Menopause

Volumn 13, Issue 5, 2006, Pages 818-825

  Nappi, Rossella E ^a   Sances, Grazia ^a,b   Sommacal, Arianna ^a   Detaddei, Silvia ^a   Facchinetti, Fabio ^b   Cristina, Silvano ^a,b   Polatti, Franco ^a   Nappi, Giuseppe ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Analgesics; Hormone therapy; Menopause; Migraine; Tension type headache; Tibolone

Indexed keywords

ANALGESIC AGENT; ESTRADIOL PLUS NORETHISTERONE ACETATE; TIBOLONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EPISODIC TENSION HEADACHE; FEMALE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MASTALGIA; MENOPAUSAL SYNDROME; MIGRAINE WITHOUT AURA; PAIN ASSESSMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SPOTTING; VAGINAL DRYNESS; VASOMOTOR DISORDER;

ANALYSIS OF VARIANCE; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEADACHE; HUMANS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 33748939771     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000227399.53192.f5     Document Type: Article

References (36)

1. Silberstein SD. The role of sex hormones in headache. Neurology 1992;42:37-42.
2. Nappi RE, Veneroni F, Chiapparini I, et al. Gonadal hormones and migraine: a tight bondage within the female brain. Semin Headache Manage 1999;4:11-15.
3. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33:385-389.
4. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population. A prevalence study. J Clin Epidemiol 1991;44:1147-1157.
5. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA 1992;267:64-69.
6. Fettes I. Migraine in the menopause. Neurology 1999;53:S29-S33.
7. Neri I, Granella F, Nappi RE, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiological study. Maturitas 1993;17:31-37.
8. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004 (Suppl 1).
9. Small R, Friedman GD, Ettinger B. Concomitant medication use in postmenopausal women using estrogen therapy. Menopause 2001;8:120-126.
10. Misakian AL, Langer RD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health 2003;12:1027-1036.
11. Hodson J, Thompson J, Al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric 2000;3:119-124.
12. Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas 2001;38:157-163.
13. Facchinetti F, Nappi RE, Tirelli A, Sances G, Polatti F, Nappi G. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002;42:924-929.
14. Swegle JM, Kelly MW. Tibolone: a unique version of hormone replacement therapy. Ann Pharmacother 2004;38:874-881.
15. Modelska K, Cummings S. Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 2002;87:16-23.
16. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425-430.
17. Zung WW. The differentiation of anxiety and depressive disorders: a biometric approach. Psychosomatics 1971;12:380-384.
18. MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin 1997;15:125-141.
19. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993;53:65-72.
20. Bono G, Neri I, Granella F, Genazzani AR, Facchinetti F. Factors associated with pain complaints in a clinical sample of postmenopausal women. J Psychosom Obstet Gynecol 1995;16:117-121.
21. MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric 1999;2:218-223.
22. de Lignieres B, MacGregor EA. Risks and benefits of hormone replacement therapy. Cephalalgia 2000;20:164-169.
23. Silberstein SD, Merriam GR. Estrogens, progestins and headache. Neurology 1991;41:786-793.
24. Rains JC, Penzien DB, Martin VT. Migraine and women's health. J Am Med Womens Assoc 2002;57:73-78.
25. Moore RA. Livial: a review of clinical studies. Br J Obstet Gynaecol 1999;106:S1-S21.
26. Ross LA, Alder EM. Tibolone and climacteric symptoms. Maturitas 1995;21:127-136.
27. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475-483.
28. Kaufman JM. Pharmacokinetics of estrogens and hormone replacement therapy. Eur Menopause J 1997;4:14-22.
29. Genazzani AR, Petraglia F, Facchinetti F, Grasso A, Alessandrini G, Volpe A. Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. Gynecol Obstet Invest 1988;26:153-159.
30. Bukulmez O, Al A, Gurdal H, Yarali H, Ulug B, Gurgan T. Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial. Fertil Steril 2001;75:737-743.
31. Davis SR. The effects of tibolone on mood and libido. Menopause 2002;9:162-170.
32. Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23:55-62.
33. Lund CO, Nilas L, Dalsgaard T, Pedersen SH, Ottesen B. Acute effects of tibolone on cerebral vascular reactivity in vitro. Climacteric 2003;6:228-237.
34. Cicinelli E, Ignarro LJ, Galantino P, Pinto V, Barba B, Schonauer S. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 2002;78:464-468.
35. Thomsen LL, Olesen J. Nitric oxide theory of migraine. Clin Neurosci 1998;5:28-33.
36. Zhu W, Smart EJ. Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 2003;14:114-117.